Diabetes and Mental Health

Diabetes Canada Clinical Practice Guidelines Expert Committee

doi:10.1016/j.jcjd.2017.10.031

Diabetes and Mental Health

Diabetes Canada Clinical Practice Guidelines Expert Committee

Medicine

Research output: Contribution to journal › Article › peer-review

138 Citations (Scopus)

Original language	English
Pages (from-to)	S130-S141
Journal	Canadian Journal of Diabetes
Volume	42
DOIs	https://doi.org/10.1016/j.jcjd.2017.10.031
Publication status	Published - Apr 2018

Bibliographical note

Funding Information:
Dr. Robinson reports personal fees from Janssen, Otsuka, Lundbeck, and Allergan, outside the submitted work. Dr. Coons has received honoraria from the Canadian Medical and Surgical Knowledge Translation Working Group. Dr. Vallis reports personal fees from Novo Nordisk, Valeant, Sanofi, Pfizer, CSL Behring, Merck, and Abbvie, outside the submitted work. Dr. Yale reports grants and personal fees from Eli Lilly Canada, Sanofi, Merck, AstraZeneca, Boehringer Ingelheim, Janssen, and Medtronic; personal fees from Novo Nordisk, Takeda, Abbott, and Bayer; and grants from Mylan. No other author has anything to disclose.

ASJC Scopus Subject Areas

Internal Medicine
Endocrinology, Diabetes and Metabolism
Endocrinology

PubMed: MeSH publication types

Journal Article

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jcjd.2017.10.031

Cite this

@article{9f34a347d3114d2f9c9d777d40ed823b,

title = "Diabetes and Mental Health",

author = "{Diabetes Canada Clinical Practice Guidelines Expert Committee} and Robinson, {David J.} and Michael Coons and Heidi Haensel and Michael Vallis and Yale, {Jean Fran{\c c}ois}",

note = "Funding Information: Dr. Robinson reports personal fees from Janssen, Otsuka, Lundbeck, and Allergan, outside the submitted work. Dr. Coons has received honoraria from the Canadian Medical and Surgical Knowledge Translation Working Group. Dr. Vallis reports personal fees from Novo Nordisk, Valeant, Sanofi, Pfizer, CSL Behring, Merck, and Abbvie, outside the submitted work. Dr. Yale reports grants and personal fees from Eli Lilly Canada, Sanofi, Merck, AstraZeneca, Boehringer Ingelheim, Janssen, and Medtronic; personal fees from Novo Nordisk, Takeda, Abbott, and Bayer; and grants from Mylan. No other author has anything to disclose.",

year = "2018",

month = apr,

doi = "10.1016/j.jcjd.2017.10.031",

language = "English",

volume = "42",

pages = "S130--S141",

journal = "Canadian Journal of Diabetes",

issn = "1499-2671",

publisher = "Canadian Diabetes Association",

}

TY - JOUR

T1 - Diabetes and Mental Health

AU - Diabetes Canada Clinical Practice Guidelines Expert Committee

AU - Robinson, David J.

AU - Coons, Michael

AU - Haensel, Heidi

AU - Vallis, Michael

AU - Yale, Jean François

N1 - Funding Information: Dr. Robinson reports personal fees from Janssen, Otsuka, Lundbeck, and Allergan, outside the submitted work. Dr. Coons has received honoraria from the Canadian Medical and Surgical Knowledge Translation Working Group. Dr. Vallis reports personal fees from Novo Nordisk, Valeant, Sanofi, Pfizer, CSL Behring, Merck, and Abbvie, outside the submitted work. Dr. Yale reports grants and personal fees from Eli Lilly Canada, Sanofi, Merck, AstraZeneca, Boehringer Ingelheim, Janssen, and Medtronic; personal fees from Novo Nordisk, Takeda, Abbott, and Bayer; and grants from Mylan. No other author has anything to disclose.

PY - 2018/4

Y1 - 2018/4

UR - http://www.scopus.com/inward/record.url?scp=85044766868&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044766868&partnerID=8YFLogxK

U2 - 10.1016/j.jcjd.2017.10.031

DO - 10.1016/j.jcjd.2017.10.031

M3 - Article

C2 - 29650085

AN - SCOPUS:85044766868

SN - 1499-2671

VL - 42

SP - S130-S141

JO - Canadian Journal of Diabetes

JF - Canadian Journal of Diabetes

ER -

Diabetes and Mental Health

Bibliographical note

ASJC Scopus Subject Areas

PubMed: MeSH publication types

UN SDGs

Access to Document

Other files and links

Cite this